Skin, Transmissibility and Infection Control
We are coating our human skin model with SARS-CoV-2 to test how long it remains viable on human skin. This allows us to investigate the efficacy of washes, sanitizers and anti-viral treatments.
The Labskin team is testing the Covid virus on skin, to determine:
- If the virus is transmissible from surfaces to airways via skin by measuring its viability when recovered from surface(s) to skin.
- To show that sanitizers kill the virus on skin (this is anecdotally assumed to be correct based on WHO research on other bacteria, but not, as far as we know, proved for Covid-19).
- To show the reduction of titer and/or virulence.
Dental Practice COVID19 Infection Risk
With the ability of Labskin to produce sensitive skin types we are also investigating consumer and pre-procedural mouthwash dental care products that may mitigate the risk of transmission in dental practices using Labskin specifically grown to mimic the oral and nasal cavities.
Given the widespread transmission of SARS-CoV-2, and reports of its spread to health care providers, dental professionals are at high risk of infection and can become potential transmission vectors for the disease. These risks can be attributed to the unique nature of dental interventions, which include aerosol generation, handling of sharps, and proximity of the provider to the patient’s oropharyngeal region. In addition, if adequate precautions are not taken, the dental care environment can potentially expose patients to cross contamination.